NADPH oxidase 2 activity in Parkinson’s disease

por Keeney, Matthew T., Hoffman, Eric K., Farmer, Kyle, Bodle, Christopher R., Fazzari, Marco, Zharikov, Alevtina, Castro, Sandra L., Hu, Xiaoping, Mortimer, Amanda, Kofler, Julia K., Cifuentes-Pagano, Eugenia, Pagano, Patrick J., Burton, Edward A., Hastings, Teresa G., Greenamyre, J. Timothy, Di Maio, Roberto
Publicado 2022

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

por Alexander, Stephen P H, Kelly, Eamonn, Mathie, Alistair, Peters, John A, Veale, Emma L, Armstrong, Jane F, Faccenda, Elena, Harding, Simon D, Pawson, Adam J, Southan, Christopher, Buneman, O Peter, Cidlowski, John A, Christopoulos, Arthur, Davenport, Anthony P, Fabbro, Doriano, Spedding, Michael, Striessnig, Jörg, Davies, Jamie A, Ahlers‐Dannen, Katelin E., Alqinyah, Mohammed, Arumugam, Thiruma V., Bodle, Christopher, Dagner, Josephine Buo, Chakravarti, Bandana, Choudhuri, Shreoshi P., Druey, Kirk M., Fisher, Rory A., Gerber, Kyle J., Hepler, John R., Hooks, Shelley B., Kantheti, Havish S., Karaj, Behirda, Layeghi‐Ghalehsoukhteh, Somayeh, Lee, Jae‐Kyung, Luo, Zili, Martemyanov, Kirill, Mascarenhas, Luke D., McNabb, Harrison, Montañez‐Miranda, Carolina, Ogujiofor, Osita, Phan, Hoa, Roman, David L., Shaw, Vincent, Sjogren, Benita, Sobey, Christopher, Spicer, Mackenzie M., Squires, Katherine E., Sutton, Laurie, Wendimu, Menbere, Wilkie, Thomas, Xie, Keqiang, Zhang, Qian, Zolghadri, Yalda
Publicado 2021